Novo Nordisk | Lucro Bruto Sobre Vendas



Gross Profit On Sales Alterar Data
ANI Pharmaceuticals USD 110.29M 134.46M 2024-12
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Bausch Health Companies USD 1.81B 130M 2024-09
Bristol-Myers Squibb USD 9.13B 94M 2024-12
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 178.93M 745K 2024-12
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 11.13B 1.86B 2024-12
GlaxoSmithKline GBP 5.56B 57M 2024-12
Merck USD 11.92B 852M 2024-12
Novartis USD 10.23B 294M 2024-12
Novo Nordisk 60B 2.22B 2024-09
Novo Nordisk DKK 60B 2.22B 2024-09
Pacira USD 147.37M 17.66M 2024-12
Perrigo USD 385.9M 18.5M 2024-12
Prestige Brands USD 161.05M 3.67M 2024-12
Sanofi EUR 10.07B 2.1B 2024-09
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Zoetis USD 1.61B 79M 2024-12



Novo Nordisk Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.